Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Funding[edit | edit source]

Grants and gifts supporting this work came from:

  • Solve ME/CFS Initiative (Ramsay Research Award)
  • HHV-6 Foundation (to B.K.P.)
  • the University of California San Diego Christini Fund
  • Lennox Foundation
  • JMS Fund
  • Khosla Foundation
  • Westreich Foundation,
  • Malone Foundation (to R.K.N.)

plus "grassroots support from over 2000 individuals who have each provided gifts in the past year to support Naviaux laboratory and Prusty laboratory research".[1]

Results[edit | edit source]

  • HHV-6 reactivation was shown to cause mitochondria dysfunction in patients with ME/CFS
  • antiviral activity was found in the blood serum of patients with ME/CFS
  • the antiviral activity was "tightly associated with an activity that fragments the mitochondrial network and decreases cellular energy (ATP) production"

Criticism[edit | edit source]

Investigators[edit | edit source]

Commentary[edit | edit source]

This paper will be a paradigm shift in our understanding of potential infectious causes behind ME/CFS. Human herpesvirus 6 and HHV-7 have long been thought to play a role in this disease, but there was hardly any causative mechanism known before — Bhupesh Prusty

News coverage[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]